An in-depth study of the scientific bibliography and years of experience with laser therapy, cryotherapy and thermotherapy has enabled our researchers to develop the HPC therapy, called “high performance combination“, which arouses particularly good effects on inflamed tissues.
Our research focused on further improving the well-known and scientifically published anti-inflammatory effects of laser and cryotherapy. With laser technology a good anti-inflammatory effect is already obtained, but an inflamed tissue in the acute phase has an excessive concentration of water molecules, which reduces, or even offsets, the therapeutic effect of the laser. An inflamed tissue in the chronic phase needs instead an increase in microcirculation.
The HPC therapy consists of the combination of the laser, the cryo- and also the thermotherapy.
It is precisely the combination of the effects of these different therapies that allows a much more effective improvement even after a few sessions.
27/01/2020 - 30/01/2020
news:
Fair "Arab Health 2020"
Dubai (UAE)
18/11/2019 - 21/11/2019
fiere e congressi:
Fair "Medica 2019"
Düsseldorf (D)
12/11/2018 - 15/11/2018
fiere e congressi:
Fair "Medica 2018"
Düsseldorf (D)
01/11/2017
news:
qmd® in Greece
Thessaloniki (GR)
13/11/2017 - 16/11/2017
fiere e congressi:
Fair "Medica 2017"
Düsseldorf (D)
22/08/2017
news:
qmd® in Slovenia
Trzin (SLO)